Since its last expansion to Ukraine in 2009, HungaroTrial CRO is glad to announce that it has expanded its reach further in 2012 to Poland and Bulgaria. This means that HungaroTrial currently has ongoing clinical development projects in 9 central and eastern european countries. The second quarter of 2012 saw the initiation of two studies in both Poland and Bulgaria respectively, headed by the HungaroTrial Regional Clinical Research Management Group.
With the addition of Poland and Bulgaria, the company has not only increased the number of countries it now works in, but strengthened its total population reach to almost 300 million people.
Share this
